NEJM Interviews
NEJM Interviews
NEJM Group
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R.A. Mikos, and Z.D. Cooper. Marijuana Rescheduling — A Game Changer for Research? N Engl J Med 2026;395:729-731.
Aug 19
13 min
NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
Eric Schneider is an adjunct professor of health policy and management at the Harvard T.H. Chan School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Chernew and E.C. Schneider. Rethinking the Role of Pay for Performance in Federal Health Care Quality Programs. N Engl J Med 2026;395:625-628.
Aug 12
8 min
NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.
Jean Nachega is a professor of infectious diseases and the director of the Biomedical Research Institute at Stellenbosch University and an associate professor at the University of Pittsburgh School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Zumla and Others. Ebola at 50 — Lessons for Outbreak Response and Preparedness. N Engl J Med 2026;395:527-529. S. Tonen-Wolyec and L. Bélec. The Social Contract of Bundibugyo Ebola Isolation. N Engl J Med. DOI: 10.1056/NEJMp2607429.
Aug 5
11 min
NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.
Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Avorn. Products That Pose Health Risks — Can Litigation Protect Us When Government Fails? N Engl J Med 2026;395:421-423.
Jul 29
14 min
NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.
Arnold Monto is a professor emeritus of epidemiology and of public health and codirector of the Center for Respiratory Virus Research and Response at the University of Michigan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Monto and H.Y. Chu. The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vaccine Protection. N Engl J Med 2026;395:313-316.
Jul 22
8 min
NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care.
Yaara Zisman-Ilani is an associate professor in the Department of Social and Behavioral Sciences at the Barnett College of Public Health and in the Department of Psychiatry and Behavioral Science at the Lewis Katz School of Medicine, both at Temple University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Zisman-Ilani and Others. Pharmacotherapeutic Decisions in Autism. N Engl J Med 2026;395:214-217.
Jul 15
8 min
NEJM Interview: Mark Unruh on projected increases in the need for long-term services and supports in the United States amid declines in nursing-home capacity.
Mark Unruh is an associate professor of population health sciences at Weill Cornell Medical College. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M.A. Unruh, V. Mor, and H.-Y. Jung. Colliding Forces — The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply. N Engl J Med 2026;395:105-107. A.R. Olenski and D.C. Grabowski. Caring for an Aging America — The Looming Crisis of the Long-Term–Care Workforce. N Engl J Med 2026;395:107-110.
Jul 8
5 min
NEJM Interview: Justin Barr on physician leadership in American society and politics over the past 250 years.
Justin Barr is a transplant surgeon at the Ochsner Clinic and a historian. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.H. Podolsky, D.S. Jones, and J. Barr. Declarations of Independence — Physicians and the U.S. Body Politic, 1776–2026. N Engl J Med 2026;395:1-3.
Jul 1
11 min
NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss.
Stacie Dusetzina is a professor of health policy and of cancer research at the Vanderbilt University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina. Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere? N Engl J Med 2026;394:2385-2387.
Jun 24
13 min
NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States.
Marcus Hughes is an assistant professor of psychiatry at the Yale School of Medicine and an attending psychiatrist at Yale New Haven Psychiatric Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Hughes. Psychedelic Therapies in the United States — Balancing State and Federal Oversight. N Engl J Med 2026;394:2281-2283. Y. Zisman-Ilani and R. Yehuda. Patient-Driven Care in Psychedelic Therapy. N Engl J Med 2026;394:2284-2286.
Jun 17
9 min
Load more